Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Added value of the tumor-stroma ratio to the PREDICT model for breast cancer.

Breast (Edinburgh, Scotland)·2026

Same author

DHX37 protein and mRNA expression patterns in breast and ovarian cancer and their prognostic implications.

Histochemistry and cell biology·2026

Same author

Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study.

Frontiers in immunology·2026

Same author

Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis.

Cell death & disease·2026

Same author

Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast Cancer.

International journal of molecular sciences·2026

Same author

Impact of Clonal Hematopoiesis of Indeterminate Potential on Treatment Response and Tumor Microenvironment in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Journal of mammary gland biology and neoplasia·2026

Same journal

Itaconate in cancer immunity: Evidence, ambiguities, and translational barriers.

Trends in cancer·2026

Same journal

Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals.

Trends in cancer·2026

Same journal

Precision neuro-oncology for children: Time to gear up!

Trends in cancer·2026

Same journal

Multi-omics analysis of extracellular vesicle cargo in cancer.

Trends in cancer·2026

Same journal

An immunological panacea for cancer-related cachexia.

Trends in cancer·2026

Same journal

Beyond one gene, one target: Next-generation precision oncology.

Trends in cancer·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 24, 2025

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

SPAG5: An Emerging Oncogene.

Ji He¹, Andrew R Green², Yan Li¹

¹The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.

Trends in Cancer

|April 16, 2020

Summary

This summary is machine-generated.

Sperm-associated Antigen 5 (SPAG5) is a mitotic spindle protein overexpressed in human cancers. This review explores SPAG5

Keywords:

SPAG5 astrin cancer therapy gene amplification oncogene therapeutic target

More Related Videos

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Related Experiment Videos

Last Updated: Dec 24, 2025

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Area of Science:

Oncology
Molecular Biology
Cell Biology

Background:

Sperm-associated Antigen 5 (SPAG5) is identified as a mitotic spindle protein.
SPAG5 overexpression is frequently observed in various human cancers.
Emerging evidence suggests SPAG5 acts as an oncogene, promoting cancer progression.

Purpose of the Study:

To summarize the molecular mechanisms by which SPAG5 exerts its oncogenic functions.
To elucidate how SPAG5 regulates critical cellular behaviors in cancer cells.
To discuss the therapeutic potential of targeting SPAG5 in cancer treatment strategies.

Main Methods:

Literature review of existing studies on SPAG5 in cancer.
Analysis of molecular pathways regulated by SPAG5.
Evaluation of SPAG5's role in cancer cell proliferation, migration, and survival.

Main Results:

SPAG5 overexpression correlates with aggressive cancer phenotypes.
SPAG5 influences cell cycle progression and chromosomal stability.
Mechanisms involve modulation of key signaling pathways critical for cancer cell behavior.

Conclusions:

SPAG5 plays a significant role in promoting oncogenesis through various cellular mechanisms.
Targeting SPAG5 presents a promising avenue for novel cancer therapies.
Further research is warranted to fully exploit SPAG5 as a therapeutic target.